Posted in | News | Consumer Robotics

Neener Analytics to Unveil World’s First AI Chat-Based Decisioning Solution at FinovateSpring 2019

Neener Analytics Inc., a leading decision analytics solution, today announces that it will unveil ARIA, its fully automated AI (artificial intelligence) & Deep Learning-driven decisioning solution, at FinovateSpring 2019 in San Francisco May 8-10, 2019.

FinovateSpring will offer more than 1,100 attendees a glimpse of the best of the Silicon Valley fintech through unique, short-form demos. Neener Analytics will use this platform to showcase ARIA, the world’s first augmented AI chat-based risk decisioning tool.

Watch a short video of ARIA at: http://www.neeneranalytics.com/aria.html

Research shows that 84% of consumers prefer chat to any other form of engagement and that 54% of consumers abandon applications. ARIA is designed to revolutionize the way a consumer engages with an application or registration process by quickly assessing the consumer’s risk quality correlated to specific individual binary financial outcomes.

ARIA can be integrated with Neener Analytics’ existing social media-based products, resulting in improved consumer engagement to reduce defaults by more than 27% and increase volume by 30%.

“We are excited to show the FinovateSpring crowd the power of ARIA,” said Neener Analytic CEO and founder Jeff LoCastro, who is ranked as one of the Top 10 Most Disruptive Entrepreneurs 2019 by MirrorReview Magazine. “ARIA enables conversation between consumers and the most advanced human personality AI, forever altering not only the way consumers engage with an application or registration process, but also forever changes decisioning itself.”

FIS Global, a global leader in financial services technology, is an investor in Neener Analytics.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.